Cavernous Sinus Thrombosis with Brit Long

Cavernous sinus thrombosis is a rare but vision- and life-threatening cause of headache, fever, and painful ocular findings after facial, sinus, or dental infection. The diagnosis turns on recognizing cranial neuropathies early, getting contrast imaging fast, and starting broad-spectrum therapy before complications spread bilaterally.

Recognizing Cavernous Sinus Thrombosis

• Venous outflow obstruction: CST is a thrombophlebitic process in the cavernous sinus that raises venous pressure, impairs orbital drainage, and produces cranial neuropathies rather than a simple localized skin infection.
• Classic symptom cluster: The bedside pattern is headache, fever, and ocular abnormalities such as chemosis, proptosis, ptosis, or ophthalmoplegia, with headache present in about 90% of cases.
• Abducens nerve vulnerability: CN VI palsy is the most common cranial nerve finding, so limited eye abduction or a lateral rectus palsy should sharply raise concern for cavernous sinus involvement.
• Rapid bilateral progression: Because the cavernous sinuses communicate across the midline, unilateral orbital findings can progress to both eyes within 48 hours. We get into the bedside pattern recognition in the episode.
• Infectious source patterns: Septic CST usually follows sinusitis or facial infection, with Staphylococcus aureus causing roughly 70% of cases; dental and other head-and-neck sources matter too.

Diagnosis and Initial Management

• Clinical diagnosis first: Normal or nonspecific labs do not exclude CST; blood cultures are positive in about 70%, but the diagnosis still rests on history, exam, and urgent imaging.
• Emergency department imaging: CT head and orbits with IV contrast and delayed-phase imaging is the practical first-line ED study, looking for filling defects, venous congestion, and sinus wall bulging.
• MRV sensitivity advantage: MR venography is the most sensitive test, around 95%, and becomes especially important when CT is unrevealing but the clinical picture still fits.
• Empiric antimicrobial backbone: Initial treatment centers on broad-spectrum IV antibiotics, typically pairing vancomycin with ceftriaxone or cefepime, with metronidazole added for dental or sinus sources.
• Anticoagulation uncertainty: Anticoagulation is considered case by case because evidence is limited, with potential benefit against clot propagation but hemorrhage and selection questions still requiring specialist input. We walk through that decision tension in the chapter.

References:

1. Long B, Field SM, Singh M, Koyfman A. High risk and low prevalence diseases: Cavernous sinus thrombosis. Am J Emerg Med. 2024 Sep;83:47-53. PMID: 38959601.
2. Coutinho J, de Bruijn SF, Deveber G, Stam J. Anticoagulation for cerebral venous sinus thrombosis. Cochrane Database Syst Rev. 2011 Aug 10;2011(8): PMID: 21833941.
3. Ebright JR, Pace MT, Niazi AF. Septic thrombosis of the cavernous sinuses. Arch Intern Med. 2001 Dec 10-24;161(22):2671-6. PMID: 11732931.